Iinyani kunye nobuxoki malunga nezidakamizwa ezixhaphakileyo
I-Tamiflu (i-oseltamivir) yinto eyaziwayo, isilwanyana esisetyenziswayo ukuphathwa okanye ukukhusela umkhuhlane (umkhuhlane) . Kuvunyiwe yi-US Food and Drug Administration (FDA) ukuphatha abantwana iiveki ezimbini okanye ngaphezulu kunye nokukhusela umkhuhlane kubantwana ezintathu okanye ngaphezulu.
Nangona ziwayo, ukusetyenziswa kweTamiflu kubantwana kuhlala kungqubuzana.
Akuqhelekanga ukuva abazali bethetha ukuba akusebenzi ngaso sonke isikhathi okanye ufunde iingxelo ezibonisa ukuba ukusetyenziswa ngokweqile kunokukhokelela ekuphuhlisweni kweengxaki zomshukela okhuseleka unyango .
Uphando lusitshelisa ntoni?
Izinzuzo zokuthatha iTamiflu
Ngokweengxelo ezivela kumaziko okuLawula nokuLawulwa kwezifo (CDC), ukusetyenziswa kwangaphambili kwezidakamizwa ze-antiviral njengoTamiflu kunokunciphisa ubude bempawu zentsholongwane, kubandakanywa nomkhuhlane, kwaye kunokunciphisa umngcipheko weengxaki (kubandakanywa ne-pneumonia, ukuhluleka ukuphefumula, kunye nokufa).
I-Tamiflu ngenye yezilwanyana ezivuthiweyo ezivuthiweyo, ezibandakanya izidakamizwa ze- Rapivab (i-peramivir) kunye nezidakamizwa ezixhaswa yi-Relenza (zanamivir) . Ngokungafani nezinye izixhobo ezikhuselweyo ezisetyenziselwa ukunyanga umkhuhlane, ezi zintathu iziyobisi ziyasebenza ekuphatheni i-influenza A kunye neentsholongwane ze-influenza B.
I-Tamiflu nayo ibalulekile kubantwana abangenakufumana ukutshatyalaliswa komkhuhlane , njengalezo eziye zadlulela kwisifo sokugonya.
Ukuhlaselwa kweTamiflu
Nangona kukho ubungqina obuxhasa ukusetyenziswa kweTamiflu kubantwana, kukho imithintelo enqande abazali ukuba bayisebenzise. Ixabiso liyinhloko phakathi kweenkxalabo, kunye nekhosi yeentsuku ezi-5 ezisebenza ngokuphezulu njenge $ 100. Nangona iindleko ze-generics eziphantsi-mali zikhoyo, ixabiso lisaba lukhulu.
Okumalunga noko kunjalo inkolelo yokuba le nkunkuma ayisebenzi. Kwiimeko ezininzi, nangona kunjalo, oku kuhambelana nokunye ukusetyenziswa kakubi kokusetyenziswa kweziyobisi.
Ukuthetha ngokuthe ngqo, ukusebenza kweTamiflu kunokuhluka xa unyango luqala. Kule nto, oogqirha bancoma ukuba isilwanyana sithathwe zingama-24 iiyure zokuqala kweempawu. Ingxaki, ewe, kukuba abazali banokuphosakela iimpawu ezincinane ezinjengeenkwenkwezi okanye umqala onqabileyo, ngakumbi ukuba umntwana ubonakala ngenye indlela.
Ngaphezu koko, isichengiselwano asiyi ku "bulala" intsholongwane emva kokusuleleka kodwa sele kunciphise ixesha kunye nobukhulu beempawu.
Ngakolunye uhlangothi, i-Tamiflu inokusebenza ngokugqithiseleyo kumntwana engakagonywanga kwaye uye wajikeleza nabanye abantwana abanomkhuhlane. Nangona kunjalo, ngenxa yokuba iinzuzo ezingabonakaliyo, abazali baya kuchitha ukusetyenziswa kwayo ngokukhusela umkhuhlane kwaye bafikelele kuphela xa kubonakala iimpawu.
Tiflu Side Effects
Umzali uvame ukudibanisa intengo kunye nokutya ukuba isilwanyana esinjengeTamiflu sinokubangela iimpawu ezingaphezulu kunokuba zikhuphe. Ngokona nxalenye, oku akunjalo.
Ngokutsho kwe-FDA, iziphumo eziqhelekileyo eziqhelekileyo ziyizicabangela kunye nokuhlanza, okuqhelekanga kungekho konke okunzima kwaye kwenzeka ezinsukwini ezimbini zokuqala unyango Ukuthatha i-Tamiflu ngokutya kudla ngokunciphisa umngcipheko wale miphumo.
Abanye bangabandakanyeka ubuhlungu besisu, iimpumpo, i-headache, kunye nokukhathala.
Iziphumo ezibi kakhulu zibikwe. Olunye uphando eJapan luye lwacebisa ukuba uTamiflu yandisa ingozi yeempawu ze-neuropsychiatric ezifana nokudideka kunye neengcamango kwaye zingakhokelela kwiingcinga zokuzilimaza okanye ukuzibulala kwabaselula. Oku kwalandelwa iingxelo ngo-2005 ukuba abatsha ababini bazibulale ngokukhawuleza emva kokusebenzisa iziyobisi.
Kuza kubekho namhlanje, akukho ziganeko ezifanayo eziye zabikwa, kwaye, ngokubhekiselele kumhlaba jikelele, ukuhlalutya kwamashishini akufumananga nayiphi na ingozi eyongeziweyo yemiphumo ye-neuropsychiatric kubasebenzisi. Xa kuthethwa oko, ukuhlaziywa kwemveliso ehlaziyiweyo kubandakanya ukucebisa ukuba i-hallucinations, ukuzilimala, kunye nokuziphatha okungavamile, ngelixa kunqabile, kunokwenzeka.
Ukukhathazeka Ngokuchasa kwiTamiflu
Njenga-antibiotics ezisetyenziselwa ukunyanga izifo ezibangelwa yi-bacteria, kukho ukukhathazeka kwangaphambili ukuba ukusetyenziswa kwe-anti-infirmic medication (ARVs) kungaqhubela phambili ekuphuhlisweni kwe-supervirus.
Okwangoku, asizange sibone oku. Ngokutsho kweCDC, ukumelana noTamiflu kuboniswe ngenye indlela yegciwane le-H1N1 ngo-2009 kodwa kwipesenti enye kuphela yeesampuli. Ngaloo ndlela, i-CDC ibona ingozi phantsi kodwa iqhubeka ijonge ukuba imeko iya kwanda.
Ukususela ngoku, ukumelana nezinye iintlobo zengcinezelo ye-A okanye ye-B ayizange ibonwe.
> Imithombo:
> Amacandelo okuLawula nokuLawula izifo. "I-Influenza Medication Anti-Viral: Isishwankathelo sezonyango." Atlanta, Georgia; hlaziywa ngoOktobha 26, 2017.
> Fiore, A .; Fry, A .; Shay, D. et al. "Ama-Agent antiviral for therapy kunye ne-Chemoprophylaxis ye-Influenza: Iingcebiso zeKomidi elicebisayo malunga neMigudu yokuPhepha (ACIP)." MMWR. NgoJanuwari 21, 2011; 60 (RR01): 1-24. PMID: 21248682.
> Ulawulo lweZiko lokuTya kunye neDrug. "I-Tamiflu Iziganeko eziMbi: Imibuzo neempendulo." Silver Spring, eMaryn; ihlaziywe ngoDisemba 7, 2015.